InvestorsHub Logo

MWM

Followers 1062
Posts 141582
Boards Moderated 14
Alias Born 03/31/2006

MWM

Re: None

Tuesday, 11/03/2020 7:34:28 AM

Tuesday, November 03, 2020 7:34:28 AM

Post# of 42562
Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
Agreement provides Humanigen up to US$20 million in milestones and double-digit royalties on product sales

Transaction supports the Humanigen Asia-Pacific regional corporate development strategy
November 03, 2020 07:30 AM Eastern Standard Time

https://www.businesswire.com/news/home/20201103005167/en/Humanigen-Executes-Licensing-Agreement-Lenzilumab